Neovasc is a medical device company that develops, manufactures and markets minimally invasive devices for the treatment of refractory angina.Read more
Neovasc's revenue is the ranked 10th among it's top 10 competitors. The top 10 competitors average 78.5M. Over the last four quarters, Neovasc's revenue has grown by 36.9%. Specifically, in Q3 2021's revenue was $ < 1M; in Q2 2021, it was $ < 1M; in Q1 2021, it was $ < 1M; in Q4 2020, Neovasc's revenue was $ < 1M.